[1] |
McMillan T, Wilson L, Ponsford J, et al. The Glasgow Outcome Scale-40 years of application and refinement[J]. Nat Rev Neurol, 2016, 12(8): 477-485.
|
[2] |
Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury[J]. Neurosurgery, 2017, 80(1): 6-15.
|
[3] |
Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention[J]. Brain Behav Immun, 2012, 26(8): 1191-1201.
|
[4] |
Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies[J]. Trends Pharmacol Sci, 2010, 31(12): 596-604.
|
[5] |
Simon DW, McGeachy MJ, Bayır H, et al. The far-reaching scope of neuroinflammation after traumatic brain injury[J]. Nat Rev Neurol, 2017, 13(3): 171-191.
|
[6] |
Woodruff TM, Ager RR, Tenner AJ, et al. The role of the complement system and the activation fragment C5a in the central nervous system[J]. Neuromolecular Med, 2010, 12(2): 179-192.
|
[7] |
Finnie JW. Neuroinflammation: beneficial and detrimental effects after traumatic brain injury[J]. Inflammopharmacology, 2013, 21(4): 309-320.
|
[8] |
Holers VM. Complement and its receptors: new insights into human disease[J]. Annu Rev Immunol, 2014, 32(1): 433-459.
|
[9] |
Dooley D, Vidal P, Hendrix S. Immunopharmacological intervention for successful neural stem cell therapy: New perspectives in CNS neurogenesis and repair[J]. Pharmacol Ther, 2014, 141(1): 21-31.
|
[10] |
Fluiter K, Opperhuizen AL, Morgan BP, et al. Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice[J]. J Immunol, 2014, 192(5): 2339-2348.
|
[11] |
Koutsoudaki PN, Papastefanaki F, Stamatakis A, et al. Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury[J]. Glia, 2016, 64(5): 763-779.
|
[12] |
Haus DL, López-Velázquez L, Gold EM, et al. Transplantation of human neural stem cells restores cognition in an immunodeficient rodent model of traumatic brain injury[J]. Exp Neurol, 2016, 281: 1-16.
|
[13] |
Bialas AR, Stevens B. TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement[J]. Nat Neurosci, 2013, 16(12): 1773-1782.
|
[14] |
Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease[J]. Annu Rev Neurosci, 2012, 35(1): 369-389.
|
[15] |
Gao M, Dong Q, Yao H, et al. Systemic administration of induced neural stem cells regulates complement activation in mouse closed head injury models[J]. Sci Rep, 2017, 7: 45989.
|
[16] |
高谋,徐如祥,王文佳,等.诱导型神经干细胞移植抑制颅脑创伤后补体活化的影响[J].中华神经创伤外科电子杂志, 2019, 5(1): 47-53.
|
[17] |
Coulthard LG, Hawksworth OA, Li R, et al. Complement C5aR1 signaling promotes polarization and proliferation of embryonic neural progenitor cells through PKCζ[J]. J Neurosci, 2017, 37(22): 5395-5407.
|
[18] |
Moriyama M, Fukuhara T, Britschgi M, et al. Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis[J]. J Neurosci, 2011, 31(11): 3981-3989.
|
[19] |
Orsini F, De Blasio D, Zangari R, et al. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis[J]. Front Cell Neurosci, 2014, 8: 380.
|
[20] |
Chu Y, Jin X, Parada I, et al. Enhanced synaptic connectivity and epilepsy in C1q knockout mice[J]. Proc Natl Acad Sci USA, 2010, 107(17): 7975-7980.
|
[21] |
Hammad A, Westacott L, Zaben M. The role of the complement system in traumatic brain injury: a review[J]. J Neuroinflamm, 2018, 15(1): 24.
|